All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
This product is the plasmid containing an encoded anti-Lung Cancer Associated Antigen (Cluster 1) DMAb sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.
Sub CAT. | DMAb Clone | DMAb Host | Target Species | DMAb Isotype | DMAb Immunogen | |
DMAb-0149-YJ | 5F263 | Mouse | Human | IgG2a | Reactive with lung cancer-associated antigen (cluster 1). Reacts with membrane-associated proteins of 120kD, 125kD and 145kD in normal and malignant tissue, including a subgroup of SCLC. Lack of reactivity with other markers within this SCLC subgroup correlates with a bad response to chemotherapy. Recommended for Brain/adrenal gland. Species Crossreactivity: Human. | |
DMAb-0150-YJ | 5F265 | Mouse | Human | IgM | Reactive with lung cancer-associated antigen (cluster 1). Reacts with a membrane-associated protein present in normal and malignant neuroendocrine tissues including a subgroup of SCLC. Lack of reactivity with other markers within this SCLC subgroup correlates with a bad response to chemotherapy. Recommended for Duodenum, bronchial tissue. Species Crossreactivity: Human. | |
DMAb-0151-YJ | 5F266 | Mouse | Human | IgG1 | Reactive with lung cancer-associated antigen (cluster 1). Reacts with a membrane-associated protein present in normal and malignant neuroendocrine tissues including SCLC. A positive reaction of MOC-52 and MOC-1 is found in most SCLC cases. The epitope is destroyed during formalin fixation. Recommended for Brain/adrenal gland. Species Crossreactivity: Human. |
There are currently no customer reviews or questions for Anti-Lung Cancer Associated Antigen (Cluster 1) DNA-encoded mAb (DMAb), pVAX1 (DMAb-0149-YJ). Click the button below to contact us or submit your feedback about this product.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION